POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Kentucky bill restricts pharmacy board from requiring electronic drug-tracking systems until federal standards are set

Original title: AN ACT relating to the regulation of pharmacists.

Last action · March 4, 2026: to Licensing, Occupations, & Administrative Regulations (H)Sponsor: Matt Koch

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

Kentucky House Bill 735 prohibits the state board from requiring s for prescription drugs until the U.S. Food and Drug Administration (FDA) implements federal standards under 21 U.S.C. sec. 355e. Additionally, the measure requires the board to consult with industry stakeholders and publish an implementation report before promulgating any related administrative regulations.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

manufacturers

Manufacturers are consulted by the board prior to rule promulgation and are subject to federal track and trace standards once implemented.

Directly affected

wholesale distributors

Wholesale distributors participate in board consultations and are subject to state electronic track and trace restrictions tied to FDA timelines.

Directly affected

pharmacies

Pharmacies are included in pre-regulation consultations and are affected by timing shifts in electronic track and trace mandates.

Key Facts

  • The board is prohibited from requiring an electronic track and trace system for prescription drugs until the FDA implements standards under 21 U.S.C. sec. 355e.
  • State electronic track and trace requirements must meet FDA standards for all covered prescription drugs.
  • Prior to promulgating administrative regulations under KRS Chapter 13A requiring an electronic track and trace system, the board must consult with manufacturers, wholesale distributors, and pharmacies.
  • The board must publish a report on its website addressing implementation issues such as universal availability, technical and operational feasibility, and reliability.

Frequently Asked Questions

When can the board require an electronic track and trace system?
The board cannot require an until the FDA develops and implements standards pursuant to 21 U.S.C. sec. 355e.
What must the board do before promulgating administrative regulations for track and trace systems?
The board must consult with manufacturers, wholesale distributors, and pharmacies regarding implementation and publish a report on its website covering issues like universal availability, technical and operational feasibility, and reliability.
What happens to existing state pedigree requirements once federal standards are implemented?
The requirements relating to a in KRS 315.406 shall be superseded by the FDA standards and shall not apply to specified prescription drugs.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

2 actions
  1. Mar 4, 2026HouseCommittee
    to Licensing, Occupations, & Administrative Regulations (H)
  2. Feb 25, 2026HouseIntroduced
    introduced in House to Committee on Committees (H)

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

FDA, KRS 315.408, 21 U.S.C. sec. 355e and 3 more
OrganizationFDA“Federal agency responsible for developing track and trace standards”Map →
otherKRS 315.408“Statute being amended by the bill”Map →
other21 U.S.C. sec. 355e“Federal statute governing FDA drug tracking standards”Map →
OrganizationGeneral Assembly“Enacting body of the Commonwealth of Kentucky”Map →
otherKRS 315.406“Statute relating to a pedigree superseded upon FDA implementation”Map →
otherKRS Chapter 13A“Chapter governing administrative regulations”Map →

Sources

Open source document

apps.legislature.ky.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 45)
  • Controversy15
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record